The Role of Cyberchondria Severity in the Relationship Between HPV Awareness and Vaccination Attitudes in Adult Women
NCT ID: NCT06800456
Last Updated: 2025-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
337 participants
OBSERVATIONAL
2024-06-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary prevention strategies include reducing sexual risk factors and administering prophylactic vaccines. Despite awareness of HPV testing, many women lack understanding of its importance and fail to follow through with screenings and necessary treatments. Overall societal awareness of HPV remains inadequate.
Studies reveal disparities in HPV vaccine awareness: while 60.7% of women have heard of the vaccine, only 1% have received it. Awareness varies widely across regions, with Turkey reporting rates from 3.8% to 57%, and vaccine awareness ranging from 2.2% to 74.7% (Özdemir et al., 2020). In the UK, concerns over potential negative results lead many women to defer HPV testing.
Health anxiety, defined as interpreting minor symptoms as serious health issues, drives individuals to seek excessive online health information, a phenomenon known as cyberchondria. Studies link cyberchondria with heightened health anxiety, exacerbated by prolonged internet searches.
Barriers to HPV screening and vaccination include fear of side effects, lack of information, cost concerns, and anxiety over potential outcomes. While women testing positive for HPV show higher levels of cyberchondria, no direct correlation has been established between cyberchondria severity and HPV awareness or vaccination attitudes in adult women.
This summary encapsulates the key findings and insights from the referenced studies on HPV, vaccination, and health anxiety.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effectiveness of the Video Prepared to Raise Cervical Cancer Awareness in Women Between the Ages of 18 and 65 Via Social Media.
NCT05385172
Knowledge, Attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
NCT06743880
Impact of HPV Education on Knowledge, Awareness, and Concern
NCT07110909
Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer
NCT06705309
What is the Optimal Training Model for Cervical Awareness?
NCT06562595
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least elementary school education
Exclusion Criteria
* Women who are HPV (Human Papilloma Virus) positive
* Any condition that would hinder communication (e.g., language barrier)
18 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acibadem University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merve Coskun
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merve Coşkun, phd
Role: PRINCIPAL_INVESTIGATOR
Acibadem University
İrem Nur Özdemir, phd
Role: PRINCIPAL_INVESTIGATOR
Bakirköy Dr.Sadi Konuk Trainng and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Güzin Ünlü Suvari
Ataşehir, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Agrawal V, Khulbe Y, Singh A, Kar SK. The digital health dilemma: Exploring cyberchondria, well-being, and smartphone addiction in medical and non-medical undergraduates. Indian J Psychiatry. 2024 Mar;66(3):256-262. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_570_23. Epub 2024 Mar 18.
Barke A, Bleichhardt G, Rief W, Doering BK. The Cyberchondria Severity Scale (CSS): German Validation and Development of a Short Form. Int J Behav Med. 2016 Oct;23(5):595-605. doi: 10.1007/s12529-016-9549-8.
Baumgartner SE, Hartmann T. The role of health anxiety in online health information search. Cyberpsychol Behav Soc Netw. 2011 Oct;14(10):613-8. doi: 10.1089/cyber.2010.0425. Epub 2011 May 6.
Dany M, Chidiac A, Nassar AH. Human papillomavirus vaccination: assessing knowledge, attitudes, and intentions of college female students in Lebanon, a developing country. Vaccine. 2015 Feb 18;33(8):1001-7. doi: 10.1016/j.vaccine.2015.01.009. Epub 2015 Jan 15.
Eskisu M, Cam Z, Boysan M. Health-Related Cognitions and Metacognitions Indirectly Contribute to the Relationships Between Impulsivity, Fear of COVID-19, and Cyberchondria. J Ration Emot Cogn Behav Ther. 2023 Jan 9:1-23. doi: 10.1007/s10942-022-00495-7. Online ahead of print.
Guvenc G, Seven M, Akyuz A. Health Belief Model Scale for Human Papilloma Virus and its Vaccination: Adaptation and Psychometric Testing. J Pediatr Adolesc Gynecol. 2016 Jun;29(3):252-8. doi: 10.1016/j.jpag.2015.09.007. Epub 2015 Sep 26.
Hendry M, Pasterfield D, Lewis R, Clements A, Damery S, Neal RD, Adke R, Weller D, Campbell C, Patnick J, Sasieni P, Hurt C, Wilson S, Wilkinson C. Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing. Br J Cancer. 2012 Jul 10;107(2):243-54. doi: 10.1038/bjc.2012.256. Epub 2012 Jun 14.
Mousavi, T., Rezapour, M., Moosazadeh, M., Ghaffari, N., & Nazari, Z. (2023). The relationship between the level of knowledge about human papillomavirus and the level of anxiety and sexual satisfaction in women with a positive HPV test. Journal of Mazandaran University of Medical Sciences, 33(2), 329-334.
Norr AM, Allan NP, Boffa JW, Raines AM, Schmidt NB. Validation of the Cyberchondria Severity Scale (CSS): replication and extension with bifactor modeling. J Anxiety Disord. 2015 Apr;31:58-64. doi: 10.1016/j.janxdis.2015.02.001. Epub 2015 Feb 14.
Ozdemir S, Akkaya R, Karasahin KE. Analysis of community-based studies related with knowledge, awareness, attitude, and behaviors towards HPV and HPV vaccine published in Turkey: A systematic review. J Turk Ger Gynecol Assoc. 2020 Jun 8;21(2):111-123. doi: 10.4274/jtgga.galenos.2019.2019.0071. Epub 2019 Aug 9.
Patel H, Moss EL, Sherman SM. HPV primary cervical screening in England: Women's awareness and attitudes. Psychooncology. 2018 Jun;27(6):1559-1564. doi: 10.1002/pon.4694. Epub 2018 Apr 16.
Starcevic V, Schimmenti A, Billieux J, Berle D. Cyberchondria in the time of the COVID-19 pandemic. Hum Behav Emerg Technol. 2021 Jan;3(1):53-62. doi: 10.1002/hbe2.233. Epub 2020 Nov 23.
Turhan Cakir A. Cyberchondria levels in women with human papilloma virus. J Obstet Gynaecol Res. 2022 Oct;48(10):2610-2614. doi: 10.1111/jog.15354. Epub 2022 Jul 8.
World Health Organization. (2021). WHO guideline for screening and treatment of cervical precancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization. Retrieved from https://www.who.int/publications/i/item/9789240014107
Yılmaz, B., Hat, B. N., Yürekli, Y., & Oskay, Ü. (2021). Genç erişkinlerin human papilloma virüs (HPV) ve hpv aşısına ilişkin bilgi ve görüşleri: Kesitsel bir çalışma. KOU Sag Bil Derg, 7(2), 138-148.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-7-268
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.